Clinical TrialsThe James Cancer Center Columbus, OH
open for enrollment
Checklist Tool in Engaging Patients in the Discharge Planning Process
Tool to Engage Patients in Discharge (TEPID)
This clinical trial studies how well a checklist tool works in engaging patients in the discharge planning process. Engaging patients in the discharge process may increase participation in the discharge process and improve discharge outcomes, understanding of care after hospitalization, and decrease complications.
I. Measure the impact on discharge and transition satisfaction of utilizing questions from the Consumer Assessment of Healthcare Providers and Systems (CHAPS) patient satisfaction survey.
II. Measure the impact of the Tool to Engage Patients in Discharge (TEPID) on patient’s Readiness for Hospital Discharge and Problems After Discharge Questionnaire-English (PADQ-E) results.
III. Measure the impact on decreasing healthcare utilization measures: readmission rates within 30 days from hospital discharge, hospital length of stay of admission in hospital, and emergency department visits within 30 days of hospital discharge.
Patients complete the TEPID checklist of items during hospital stay.
After completion of the study, patients are followed up for 35 days.
Are you eligible?
Patients fluent in English, conscious, coherent, and alert or have an adult caregiver present that is fluent in English will be identified for the TEPID research project
Patients discharged to another inpatient facility (hospice, skilled nursing facility, long term acute care hospital [LTACH], or acute rehab) or patients discharged home with hospice will be excluded
Any patients that are transferred to another unit prior to discharge will be excluded